Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate

Clinical trial NCT03582475 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03582475
Sponsor: Jonsson Comprehensive Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Bladder Small Cell Neuroendocrine Carcinoma Castration-Resistant Prostate Carcinoma Metastatic Bladder Urothelial Carcinoma Metastatic Urethral Urothelial Carcinoma Prostate Carcinoma Metastatic in the Bone Prostate Neuroendocrine Neoplasm Prostate Small Cell Carcinoma Stage III Bladder Cancer American Joint Committee on Cancer ( AJCC) v8 Stage III Prostate Cancer AJCC v8 Stage III Urethral Cancer AJCC v8 Stage IV Bladder Cancer AJCC v8 Stage IV Prostate Cancer AJCC v8

Start date: 2019-01-11
Primary completion: 2025-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.